|Potency||300 mg / ml|
|Appearance||oil based solution|
|Packing||1ml *10 clear glass ampoules*|
|Indications||EQUIPOISE (Boldenone undecylenate) is an anabolic steroid indicated for treatment of muscle atrophy in cancer patients and HIV/AIDS patients.|
* Supplied in a clear 1ml glass ampoules with breaking line and labeled box
* Contains ethyl oleate
Notes on temperatures the properties:
At cold storage temperatures the properties of this oil-based solution might temporarily change (e.g. higher viscosity, cloudiness). If stored at cold temperature, the product should be brought to room or body temperature before use. The solution for intramuscular injection is to be visually inspected prior to use and only clear solutions free from particles should be used.
Notes on handling the OPC (One-Point-Cut) ampoule:
There is a pre-scored mark beneath the coloured point on the ampoule eliminating the need to file the neck. Prior to opening, ensure that any solution in the upper part of the ampoule flows down to the lower part. Ensure that temperature of ampule is between 33-38 °C. Use both hands to open; while holding the lower part of the ampoule in one hand, use the other hand to break off the upper part of the ampoule in the direction away from the coloured point.
Store at room temperature, 15° – 30°C (59° – 86°F).
Avoid freezing and cool temperatures below 15°(59°F).
If freezing occurs and crystals are present, contact the manufacturer representative.
Boldenone undecylenate, or boldenone undecenoate, sold under the brand names Equipoise and Parenabol among others, is an androgen and anabolic steroid (AAS) medication which is used in veterinary medicine, mainly in horses. It was formerly used in humans as well. It is given by injection into muscle. Side effects of boldenone undecylenate include symptoms of masculinization like acne, increased hair growth, voice changes, and increased sexual desire. The drug is a synthetic androgen and anabolic steroid and hence is an agonist of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT). It has strong anabolic effects and moderate androgenic effects, weak estrogenic effects, and no risk of liver damage. Boldenone undecylenate is an androgen ester and a long-lasting prodrug of boldenone in the body. Boldenone undecylenate was introduced for medical use in the 1960s. In addition to its medical use, boldenone undecylenate is used to improve physique and performance. The drug is a controlled substance in many countries and so non-medical use is generally illicit. It remains marketed for veterinary use in Australia and the United States.
Studies conducted in laboratory animals to evaluate pharmacological activity characterized boldenone undecylenate as having distinct anabolic properties together with a certain degree of androgenic activity. It does not have marked antigonadotrophic properties, nor does it produce any clear-cut effects on the endometrium, conditions that are commonly observed when similar substances are used.
In clinical trials at the recommended dosage, EQUIPOISE injectable had a marked anabolic effect in debilitated horses, appetite improved, weight gain was noted, vigor increased and improvement was noted in musculature and haircoat. This would be expected with an anabolic agent such as EQUIPOISE injectable, particularly where there had been marked tissue breakdown associated with disease, prolonged anorexia or overwork.